Practical implementation of cryonics: cryoprotectants, freezing, and vitrification.
Problems and prospects of cryonics: a multifaceted view.


Practical implementation of cryonics: cryoprotectants, freezing, and vitrification

Cryoprotectants are substances that shield biological objects from the damaging effects of freezing.
They are essential for cryopreservation—the low-temperature storage of living materials such as cell cultures, blood, sperm, embryos, isolated organs, and even entire organisms.
The quality and safety of cryopreserved tissues hinge on these agents, as they preserve the viability and functionality of cells over long periods.

Cryoprotectants are broadly divided into two categories: penetrating and non-penetrating.

  • Penetrating cryoprotectants enter the cell and prevent the formation of intracellular ice crystals, which can destroy cellular structures.
    Examples include glycerol, ethylene glycol, dimethyl sulfoxide (DMSO), and propylene glycol.
  • Non-penetrating cryoprotectants remain in the extracellular fluid, preventing cellular dehydration that can lead to membrane damage and protein denaturation.
    Examples include sucrose, trehalose, and polyethylene glycol (PEG).

The selection of cryoprotectants must be tailored to the specific biological object, as different agents have varied effects.
For instance, some may be toxic at high concentrations or after prolonged exposure, while others can cause oxidative stress, apoptosis, or affect genetic stability and cell differentiation.
Therefore, controlling the concentration, exposure time, and the rate of introduction and removal of these agents is critical.

Cryoprotectants are particularly vital in the cryopreservation of reproductive tissue, offering a way to preserve fertility for individuals undergoing treatments (like for cancer) that risk causing premature ovarian failure or infertility.
This process involves freezing and storing ovarian or testicular tissue containing primordial follicles for later transplantation back into the patient.

The primary methods used for cryopreservation are:

  1. Slow Freezing: This process involves a cooling rate of 0.1 to 10°C per minute.
    The extracellular fluid freezes first, drawing water out of the cells and increasing the intracellular concentration of cryoprotectants.
    This helps prevent intracellular ice formation but can lead to other cryoinjuries, such as protein denaturation and membrane damage.
    Slow freezing is commonly used for blood, sperm, early-stage embryos, and stem cells.
  2. Rapid Freezing: With a cooling rate exceeding 10°C per minute, both intracellular and extracellular fluids freeze almost simultaneously.
    This can cause the formation of damaging intracellular ice.
    To mitigate this, high concentrations of cryoprotectants are used to lower the freezing point of water (to -60°C or below) and protect the cells.
    This method is often applied to oocytes, late-stage embryos, and vascular tissue.
  3. Vitrification: This advanced method involves cooling so rapidly that water molecules do not have time to form ice crystals and instead solidify into a glass-like, amorphous state.
    It requires very high concentrations of cryoprotectants (often over 60%) to achieve the necessary viscosity.
    While vitrification effectively avoids ice-related damage, it introduces risks like cryoprotectant toxicity and osmotic stress.
    It is considered the most promising method for oocytes, embryos, and ovarian tissue due to its high success rates in preserving viability.

The cryonics procedure: key steps

The practical application of cryonics involves three main stages:

  1. Cryopreservation (Freezing): Following legal declaration of death and before cellular decay begins, the body’s temperature is lowered to a point where all metabolic activity ceases.
    Special cryoprotectant solutions are perfused through the body to protect cells and tissues from ice formation. This can be applied to the whole body or just the head (neuropreservation).
  2. Long-Term Storage: The body is maintained at a stable, cryogenic temperature (around -196°C in liquid nitrogen) where no further degradation occurs.
    This is done in specialized containers called cryostats, managed by cryonics organizations that ensure security and monitoring.
    Storage is indefinite, pending the development of future revival technologies.
  3. Revival (Theoretical): This future stage involves rewarming the body and restoring biological function.
    It would rely on highly advanced molecular technologies, such as nanotechnology, to repair cellular damage incurred during the freezing process and to cure the original cause of death and reverse the effects of aging.
    The success of this stage is entirely hypothetical and depends on future scientific breakthroughs.

Problems and prospects of cryonics: a multifaceted view

Cryonics is a speculative technology that offers hope for a future life, but it faces significant ethical, social, psychological, scientific, and technological challenges.

1. Ethical challenges

Arguments Against Cryonics:

  • It interferes with the natural order of life and death.
  • It may conflict with religious or moral beliefs about the soul and the afterlife.
  • It could foster an illusion of immortality, potentially devaluing life’s meaning.
  • It raises questions about personal identity and human dignity.
  • There is no guarantee of a safe and successful revival or a desirable quality of life in the future.
  • It is inherently inequitable, accessible only to the wealthy.

Arguments For Cryonics:

  • It respects an individual’s right to choose life and to self-determination.
  • It expands the boundaries of human freedom and possibility.
  • It provides hope and a sense of purpose in the face of terminal illness.
  • It aims to preserve personal identity and dignity, not diminish them.
  • It drives scientific and technological advancement.
  • It could potentially yield benefits for society and medicine.

2. Social hurdles

The social challenges of cryonics stem from its novelty and lack of public understanding.

  • Legal Ambiguity: Cryonics operates in a legal gray area.
    There is a lack of clear laws regarding the rights of cryopreserved individuals, which creates complications for matters like inheritance, insurance, and marital status.
  • Public Perception: The technology is often met with misunderstanding, skepticism, and denial from the general public.
    This can lead to social stigma and potential conflicts between those who opt for cryopreservation and the rest of society.

Future Social Prospects: If cryonics can demonstrate its viability, it may gain greater public trust and support.
This could lead to the development of a robust legal framework, financial instruments to make it more accessible, and wider societal acceptance through education and outreach.

3. Psychological impact

Cryonics presents unique psychological challenges for both the individuals choosing it and their families.

  • Uncertainty and Anxiety: The experimental nature of the technology and the unknown future can cause significant fear, anxiety, and a feeling of loss of control.
  • Grief and Closure: For family members, the process can complicate grieving, as their loved one is neither truly alive nor permanently gone.

Psychological Hope: On the other hand, cryonics can provide immense hope, offering a chance to overcome death.
This can be a powerful coping mechanism and a source of meaning for those facing their mortality.

4. Scientific obstacles

  • Incomplete Knowledge: Our understanding of the mechanisms of aging and cellular decay is still incomplete.
  • Cryoinjury: The damage caused by freezing and thawing at the cellular level is not yet fully reversible with current technology.
  • Lack of Proven Methods: There are no established technologies to safely and effectively cryopreserve and revive a whole human being.

Scientific Prospects: Research in cryonics could accelerate discoveries in biology, particularly in areas like aging, cellular repair, and tissue engineering.
Advances in these fields are essential for cryonics to become a reality and could have broad applications in medicine.

5. Technological limitations

  • Equipment and Personnel: There is a shortage of specialized equipment, optimal materials, and highly trained personnel to perform cryopreservation procedures to the highest standard.
  • Irreversible Damage: Current technology cannot prevent all cellular damage during the process.
  • High Cost: The procedure is extremely expensive, limiting its accessibility.
  • Security Risks: Cryostats are valuable and vulnerable to sabotage, accidents, or institutional failure over the long term.

Technological Prospects: Future technological developments could lead to more sophisticated equipment, better cryoprotectants, and refined procedures, improving the quality and reducing the cost of cryopreservation.
Enhanced security and reliability of storage facilities are also critical areas for improvement.

Conclusion to chapter 3

Cryonics remains an experimental and controversial field, built on unproven hypotheses and a profound hope in future technological capabilities.
While it holds the potential for future revival, its success is contingent on monumental scientific breakthroughs to reverse freezing-induced damage and cure terminal diseases.
Realizing this potential will require immense investment, robust regulation, and widespread scientific and social support.


Mummification, cryonics, and transplantology: the evolution of organ and tissue preservation and transfer technologies.
A Research Study.
1. From mummification to transplantation: a comparative study of life preservation technologies→
2. Mummification: ancient practices and modern research.
A history of mummification in different cultures: Egypt, China, India, and South America→

2.1. The influence of mummification on the history of science: anatomy, medicine, chemistry, and biology.
Modern research on mummies: methods and scientific discoveries→

3. Cryonics: the theory and practice of preserving life by freezing→
3.1. Practical implementation of cryonics: cryoprotectants, freezing, and vitrification.
Problems and prospects of cryonics: a multifaceted view→
4. Transplantology: organ and tissue transplantation.
The history of transplantology: from early experiments to clinical practice and public acceptance→

4.1. Organ and tissue transplantation: types, methods, indications, contraindications, and outcomes→
4.2. Cryopreservation of organs and tissues for transplantation: goals, principles, technologies, and efficacy.
Challenges and prospects in transplantation medicine: immunological, infectious, oncological, ethical, and organizational aspects→

5. Conclusion: a comparative analysis of mummification, cryonics, and transplantology→
5.1. Directions for Further Research→

Other articles about my school projects→
This article in Russian→